-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc.
The Deal Details
Under the deal between HAVN Life, its newly incorporated, wholly-owned subsidiary, 1000053494 Ontario Inc. and Spore, HAVN Subco and Spore agreed to merge and continue as one corporation.
The holders of common shares of Spore will receive an aggregate of 95 million common shares of the HAVN Life for the Spore Shares issued and outstanding prior to closing.
Moreover, HAVN Life will receive one common share of Amalco for each common share of HAVN Subco held by HAVN Life.
In addition, in consideration of the issuance of the HAVN shares, Amalco agreed to issue to HAVN Life one Amalco share for each HAVN share issued.
HAVN Life agreed to issue up to $11 million worth of common shares to the former shareholders of Spore and up to $19 million worth of common shares to certain consultants that will join HAVN Life upon completion of the deal upon achieving several milestones.
What It Means For Havn Life
HAVN Life CEO Tim Moore said the deal is set to strengthen the company's position as "a leader in brain health-focused nutritional supplements."
Toronto-based Spore Life Sciences Inc. is a wellness brand focused on functional mushroom formulations.
Co-founded by CEO and president Michael Zavet, Spore boasts a significant U.S. consumer base of more than 110,000 customers, nearly 40,000 subscribers, resulting in year-to-date revenues as of the end of November 2021 of nearly CAD$8 million and current sales of more than $1 million per month.
What's Next?
Zavet said Spore is "excited to support HAVN's psychedelic endeavors through our digital marketing channels and large customer base."
The completion of the acquisition will bring in nine additional formulations under the HAVN Life retail brand, adding to its growing selection of natural health products that support overall health and cognitive function.
HAVLF Price Action
HAVN Life Sciences' shares traded 11.73% higher at $0.14 per share at the time of writing on Monday morning.
Photo: Courtesy of Mari-Liis Link on Unsplash
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc.
生物技術公司HAVN生命科學公司。(CSE：HAVN)(場外交易：HAVLF)為採購功能性蘑菇保健品牌孢子生命科學公司。
The Deal Details
交易詳情
Under the deal between HAVN Life, its newly incorporated, wholly-owned subsidiary, 1000053494 Ontario Inc. and Spore, HAVN Subco and Spore agreed to merge and continue as one corporation.
在.之下HAVN Life和HAVN Life之間的交易它是新成立的，全資子公司安大略省1000053494公司和孢子公司、HAVN Subco和孢子公司同意合併，並作為一個公司繼續存在。
The holders of common shares of Spore will receive an aggregate of 95 million common shares of the HAVN Life for the Spore Shares issued and outstanding prior to closing.
這個孢子公司普通股的持有者將獲得總計9500萬股HAVN Life的普通股對於在收盤前已發行和已發行的孢子股票。
Moreover, HAVN Life will receive one common share of Amalco for each common share of HAVN Subco held by HAVN Life.
此外，HAVN Life每持有一股HAVN Subco普通股，將獲得一股Amalco普通股。
In addition, in consideration of the issuance of the HAVN shares, Amalco agreed to issue to HAVN Life one Amalco share for each HAVN share issued.
此外，考慮到HAVN股票的發行，Amalco同意以每發行一股HAVN股票的方式向HAVN Life發行一股Amalco股票。
HAVN Life agreed to issue up to $11 million worth of common shares to the former shareholders of Spore and up to $19 million worth of common shares to certain consultants that will join HAVN Life upon completion of the deal upon achieving several milestones.
哈文人壽同意發行價值高達1100萬美元的普通股給孢子公司的前股東，最高可達向將加入HAVN Life的某些顧問提供價值1900萬美元的普通股在實現幾個里程碑的情況下完成交易。
What It Means For Havn Life
這對Havn Life意味着什麼
HAVN Life CEO Tim Moore said the deal is set to strengthen the company's position as "a leader in brain health-focused nutritional supplements."
哈文人壽首席執行官蒂姆·摩爾他説，這筆交易將鞏固該公司作為“專注於大腦健康的營養補充劑的領導者”的地位。
Toronto-based Spore Life Sciences Inc. is a wellness brand focused on functional mushroom formulations.
總部位於多倫多的孢子生命科學公司是一家專注於功能性蘑菇配方的健康品牌。
Co-founded by CEO and president Michael Zavet, Spore boasts a significant U.S. consumer base of more than 110,000 customers, nearly 40,000 subscribers, resulting in year-to-date revenues as of the end of November 2021 of nearly CAD$8 million and current sales of more than $1 million per month.
由孢子公司首席執行官兼總裁邁克爾·扎維特該公司在美國擁有超過11萬客户和近4萬訂户的龐大消費者基礎，截至2021年11月底，今年迄今的收入接近800萬加元，目前每月銷售額超過100萬美元。
What's Next?
下一個是什麼？
Zavet said Spore is "excited to support HAVN's psychedelic endeavors through our digital marketing channels and large customer base."
扎維特説，孢子“很高興能通過我們的數字營銷渠道和龐大的客户基礎支持HAVN的迷幻努力。”
The completion of the acquisition will bring in nine additional formulations under the HAVN Life retail brand, adding to its growing selection of natural health products that support overall health and cognitive function.
收購完成後，在HAVN Life零售品牌下增加了九種配方，增加了其越來越多的天然保健品選擇，支持整體健康和認知功能。
HAVLF Price Action
HAVLF價格行動
HAVN Life Sciences' shares traded 11.73% higher at $0.14 per share at the time of writing on Monday morning.
擁有“生命科學”(HAvn Life Science)股價上漲11.73%，至每股0.14美元。在我寫這篇文章的時候，是在週一早上。
Photo: Courtesy of Mari-Liis Link on Unsplash
圖片：Unspash上的Mari-Liis Link提供
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧